
    
      Children aged 3-16 years with a medical diagnosis of asthma, will be assessed for asthma
      control, exacerbation rate.

      Data will be compared to data from other observational cohorts conducted in the same region
      prior to the pandemic.

      A sub-population of children 3-16 years will be assessed at exacerbation and at a follow-up
      visit, 2-4 months later, with clinical data, biological and microbiological samples.
    
  